New Retina Radio:

New Retina Radio Journal Club

New Retina Radio Journal Club

02.10.21

New Retina Radio Journal Club: Phase 2 LADDER Study Data

Aleksandra Rachitskaya, MD, leads a discussion with Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD, about the phase 2 LADDER study, which evaluated the Port Delivery System With Ranibizumab (Genentech) in patients with wet AMD. Listen to a summary of the study and a thorough discussion of its implications with this group of Vit-Buckle Society members.  This editorially independent podcast is supported with advertising.

Watch This Episode as a Video

02.10.2021

New Retina Radio Journal Club: Phase 2 LADDER Study Data

Aleksandra Rachitskaya, MD; Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD

Other Podcast Episodes

07.18.25

Diabetic Retinopathy Severity and Income Status

Ben Young, MD; Phoebe Mellen, MD; and Jordan Deaner, MD

06.20.25

Photobiomodulation for Age-related Macular Degeneration

Moderator Barton Blackorby, MD; Hong-Uyen Hua, MD; and Louis Cai, MD

03.21.25

Rates of Ocular AEs After Faricimab Injection

Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD

12.19.24

Switching from Aflibercept to Faricimab in Wet AMD Patients

Ben Young, MD, MS; Lediana Goduni, MD; and Joshua Uhr, MD,

11.21.24

New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?

Moderator Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD

09.17.24

New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAO

Katherine Talcott, MD; Kyle Kovacs, MD; and Phoebe Mellen, MD

Show More